LIPI COOPERATION WITH BIO PHARMACY

Head LIPI Iskandar Zulkarnain (left) symbolically handed the EPO-Erythopoetin to Dirut PT. Bio Farma Iskandar (right) as the signing of MTA on the Submission of Research Cell Bank (RCB) development of the manufacture of Erythopoetin (EPO) Second Generation of the Indonesian Science Institute (LIPI) to PT. Bio Farma, in Bandung, West Java, Monday (28/12). This partnership is characterized by the submission of RCB EPO from P2 Biotech LIPI Cibinong to PT. Bio Farma who later developed and prepared to be a product to help treatment as well as therapy in blood wash patients, chemotherapy and anemia. ANTARA PHOTO/Fahrul Jayadiputra/foc/15.

The caption is automatically translated by application. Click here for the Bahasa Indonesia version.